{"id":1701,"date":"2025-08-11T16:42:39","date_gmt":"2025-08-11T16:42:39","guid":{"rendered":"https:\/\/retrotradingreport.com\/index.php\/2025\/08\/11\/cannabis-stocks-soar-on-trump-reclassification-speculation\/"},"modified":"2025-08-11T16:42:39","modified_gmt":"2025-08-11T16:42:39","slug":"cannabis-stocks-soar-on-trump-reclassification-speculation","status":"publish","type":"post","link":"https:\/\/retrotradingreport.com\/index.php\/2025\/08\/11\/cannabis-stocks-soar-on-trump-reclassification-speculation\/","title":{"rendered":"Cannabis stocks soar on Trump reclassification speculation"},"content":{"rendered":"<div><\/div>\n<p>Following a <a target=\"_blank\" href=\"https:\/\/www.wsj.com\/politics\/policy\/trump-marijuana-federal-drug-classification-01a73b8c\">Wall Street Journal report<\/a>, cannabis stocks surged Monday due to speculation that US President Donald Trump is considering reclassifying marijuana to a lower danger level.<\/p>\n<p>Canopy Growth and Tilray Brands both saw surges of over 12% on Monday.&nbsp;<\/p>\n<p>Cronos Group climbed more than 5%, reaching a new 52-week high in early trading, according to a <a target=\"_blank\" href=\"https:\/\/www.cnbc.com\/2025\/08\/11\/cannabis-stocks-trump-considering-reclassification-weed.html\">CNBC report<\/a>. <\/p>\n<p>Similarly, the AdvisorShares Pure US Cannabis ETF (MSOS) and Amplify Alternative Harvest ETF (MJ) each experienced gains exceeding 10%.<\/p>\n<h2 class=\"wp-block-heading\">Low price point<\/h2>\n<p>Many cannabis stocks in the sector trade at remarkably low prices, often less than a dollar per share.&nbsp;<\/p>\n<p>This low price point means that even small fluctuations of a few cents can translate into substantial percentage changes in stock value, making these stocks highly volatile.&nbsp;<\/p>\n<p>Despite a recent rally, which saw some positive movement on Monday, the majority of these cannabis stocks remain far below their historical all-time highs.&nbsp;<\/p>\n<p>Investors in this sector are currently navigating a high-risk landscape, where the potential for significant gains is accompanied by an equally high risk of further declines.&nbsp;<\/p>\n<p>The future trajectory of these stocks will largely depend on evolving regulatory frameworks, improved market demand, and the ability of individual companies to execute sustainable business models.<\/p>\n<p>Earlier this month, Trump discussed the issue at a fundraiser held at his New Jersey golf club, according to attendees.<\/p>\n<h2 class=\"wp-block-heading\">Federal change<\/h2>\n<p>Under US federal law, the classification of cannabis as a Schedule I drug places it in the most restrictive category, signifying a high potential for abuse and no accepted medical use.&nbsp;<\/p>\n<p>This categorisation, which includes substances like heroin and cocaine, has significant implications for research, medical applications, and legal enforcement.&nbsp;<\/p>\n<p>Historically, discussions regarding the reclassification of cannabis have often revolved around moving it to Schedule III.&nbsp;<\/p>\n<p>This less restrictive category includes drugs with a moderate to low potential for physical and psychological dependence, such as anabolic steroids and certain pain medications like Tylenol with codeine.&nbsp;<\/p>\n<p>Such a reclassification would acknowledge potential medical benefits and facilitate further research into its therapeutic applications, while still maintaining some federal control.&nbsp;<\/p>\n<p>The ongoing debate highlights a significant divergence between federal law and the increasing number of states that have legalized cannabis for medical or recreational use, creating a complex legal and regulatory landscape.<\/p>\n<h2 class=\"wp-block-heading\">Reclassification benefits<\/h2>\n<p>Reclassifying marijuana companies would bring about various advantages, including different tax regulations and increased investment appeal.<\/p>\n<p>Tim Seymour, investing chief at Seymour Asset Management, was quoted in the CNBC report on Monday, stating that a shift from Schedule 1 to Schedule 3 could &#8220;change the game&#8221; for the approximately $80 billion market.&nbsp;<\/p>\n<p>He also observed that this change appears to have bipartisan backing.<\/p>\n<blockquote class=\"wp-block-quote inv-component-break-container is-layout-flow wp-block-quote inv-component-break-container-is-layout-flow\">\n<p>It does not mean that it won\u2019t be a complicated trade,\u201d Seymour said. \u201cBut it does mean that you\u2019re investing now well ahead of a lot of institutional capital if you are, in fact, investing into this sector.<\/p>\n<\/blockquote>\n<p>While Trump&#8217;s support can improve the prospects for reclassifying the drug, he lacks the unilateral authority to do so.&nbsp;<\/p>\n<p>The power to reclassify substances under the Controlled Substances Act rests with the Attorney General, who has historically delegated this authority to the administrator of the Drug Enforcement Administration.<\/p>\n<p>The post <a href=\"https:\/\/invezz.com\/news\/2025\/08\/11\/cannabis-stocks-soar-on-trump-reclassification-speculation\/\">Cannabis stocks soar on Trump reclassification speculation<\/a> appeared first on <a href=\"https:\/\/invezz.com\/\">Invezz<\/a><\/p>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Following a Wall Street Journal report, cannabis stocks surged Monday due to speculation that US President Donald Trump is considering reclassifying marijuana to a lower danger level.Canopy Growth and Tilray Brands both saw surges of over 12% on Monday.&nbsp;Cronos Group climbed more than 5%, reaching a new 52-week high in early trading, according to a&hellip;<\/p>\n","protected":false},"author":1,"featured_media":1702,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-1701","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investing"],"_links":{"self":[{"href":"https:\/\/retrotradingreport.com\/index.php\/wp-json\/wp\/v2\/posts\/1701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/retrotradingreport.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/retrotradingreport.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/retrotradingreport.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/retrotradingreport.com\/index.php\/wp-json\/wp\/v2\/comments?post=1701"}],"version-history":[{"count":0,"href":"https:\/\/retrotradingreport.com\/index.php\/wp-json\/wp\/v2\/posts\/1701\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/retrotradingreport.com\/index.php\/wp-json\/wp\/v2\/media\/1702"}],"wp:attachment":[{"href":"https:\/\/retrotradingreport.com\/index.php\/wp-json\/wp\/v2\/media?parent=1701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/retrotradingreport.com\/index.php\/wp-json\/wp\/v2\/categories?post=1701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/retrotradingreport.com\/index.php\/wp-json\/wp\/v2\/tags?post=1701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}